- Home
- IVR vs PRME Comparison
IVR vs PRME Comparison
Compare IVR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVR | PRME |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.0M | 601.1M |
| IPO Year | 2009 | 2022 |
Fundamental Metrics
Financial Performance| Metric | IVR | PRME |
|---|---|---|
| Price | $8.15 | $3.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $7.50 | ★ $9.31 |
| AVG Volume (30 Days) | 1.3M | ★ 3.9M |
| Earning Date | 10-30-2025 | 11-07-2025 |
| Dividend Yield | ★ 16.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $72,304,000.00 | $5,977,000.00 |
| Revenue This Year | $266.55 | $179.58 |
| Revenue Next Year | $4.36 | N/A |
| P/E Ratio | $15.23 | ★ N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $5.86 | $1.11 |
| 52 Week High | $9.06 | $6.94 |
Technical Indicators
Market Signals| Indicator | IVR | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 69.54 | 37.60 |
| Support Level | $8.10 | $3.57 |
| Resistance Level | $7.89 | $3.89 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 88.33 | 14.94 |
Price Performance
Historical ComparisonAbout IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.